DUBLIN, Dec. 10, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/gb4hhf/cancer_testing) has announced the addition of the "Cancer Testing Market in the US 2015-2019" report to their offering.
This report provides a number of factors contributing to the adoption, limitations, and opportunities of the cancer testing market in the US. It also offers an analysis of each factor and an estimation of the extent to which the factors are likely to impact the overall market growth.
Use of bench-top mass spectrometers is one of the major trends for the market since this technology helps in detection of diseases in small quantities of samples. This technology has revolutionized the field of proteomics, genomics, and lipidomics by increasing the throughput for sample analysis. Another trend witnessed by the market is ready-to-use reagents.
According to the report, changes in the healthcare system are a prime driver for the market growth during the forecast period. The number of US citizens covered under healthcare insurance has increased and today 19 million citizens in the US have insurance coverage. Also, insurance policies are provided by large companies to their employees. This is expected to fuel market growth. Increase in demand for personalized medicines, increase in molecular testing, and increase in demand for POC testing are the other major drivers that are expected to fuel market growth.
Further, the report states that there are certain challenges that are expected to limit the market growth during the forecast period. One such challenge is regulatory and reimbursement issues faced by the vendors since the government's introduction of medical device excise tax and cuts in bundled payments restricts usage by customers.
Key questions answered in the report include:
- What will the market size and the growth rate be in 2019
- What are the key factors driving the cancer testing market in the US
- What are the key Market trendss impacting the growth of the cancer testing market in the US
- What are the challenges to market growth
- Who are the key vendors in the cancer testing market in the US
- What are the market opportunities and threats faced by the vendors in the cancer testing market in the US
- What are the key outcomes of the five forces analysis of the cancer testing market in the US
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: US healthcare reform
PART 06: Reimbursement and coverage: an overview
PART 07: Market landscape
PART 08: Market segmentation by technique
PART 09: Market drivers
PART 10: Impact of drivers
PART 11: Market challenges
PART 12: Impact of drivers and challenges
PART 13: Market trends
PART 14: Vendor landscape
PART 15: Key vendor analysis
- Abbott Diagnostics
- Agilent Technologies
- Beckman Coulter
- Roche Diagnostics
Other Prominent Vendors:
- Bio-Rad Laboratories
- Cardinal Health
- Fujirebio Diagnostics
- Johnson & Johnson
- Pathway Genomics
- Quest Diagnostics
- Rosetta Genomics.
For more information visit http://www.researchandmarkets.com/research/gb4hhf/cancer_testing
Laura Wood, +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets